Objective: Plasma B-group vitamins and age may affect the carotid intima-media thickness (IMT) in subjects with different 677TT genotype of the methylenetetrahydrofolate reductase (MTHFR) gene. Design: A hospital-based cross-study. Setting: Genomic and Vascular Center, Changhua Christian Hospital, Changhua, Taiwan. Subjects: Five hundred and forty-one clinically healthy subjects. Intervention: Fasting plasma, homocysteine (Hcy), vitamin B 6 , vitamin B 12 , folate and B-mode carotid ultrasound. Results: MTHFR genotype, plasma concentrations of folate, vitamin B 6 and vitamin B 12 and age were significantly correlated to the plasma Hcy concentration. MTHFR 677TT carriers had higher concentrations of Hcy than did subjects with the CC and CT genotypes. Age, sex, body mass index and plasma Hcy were independent contributors to increase carotid IMT. However, with stratification by mean value of age and B-group vitamins concentrations, we found that at advanced age, lower plasma folate and vitamin B 12 were three risk factors involved in the enhancing effect of the MTHFR 677TT genotype on the increase of plasma Hcy and carotid IMT. Conclusion: MTHFR 677TT-related carotid atherosclerosis was only identified in healthy elderly subjects with lower level of plasma folate and vitamin B 12 . Sponsorship: Changhua Christian Hospital.
Introduction
The N 5 ,N 10 -Methylenetetrahydrofolate reductase (MTHFR) 677TT genotype affects folate metabolism because of reduced affinity of the enzyme for MTHFR and the riboflavin cofactor FAD. The reduced enzyme activity leads to decreased synthesis of MTHFR, the substrate for the conversion of homocysteine (Hcy) to methionine, catalyzed by the vitamin B 12 -dependent enzyme, methionine synthase. Thus, it can be predicted that the MTHFR gene polymorphism will lead to the accumulation of unmetabolized Hcy, which in turn may increase the risk of vascular-related problems such as increased carotid intima-media thickness (IMT). Importantly, increasing the supply of folate can overcome the reduced affinity of MTHFR for its substrate and cofactor, and thus overcome the effect of the gene polymorphism on Hcy metabolism. The increase in mean IMT in the carotid arteries is often used as a marker in the study of atherosclerosis and effective in the incidence prediction of ischemic heart or brain event (Burke et al., 1995; Bots et al., 1997; O'Leary et al., 1999) . However, whether the polymorphism of MTHFR gene contributes to carotid atherosclerosis is unclear. The MTHFR C677T polymorphism was reported to affect the carotid atherosclerosis in an ageing population (Kawamoto et al., 2001; de Maat et al., 2003) , in women (Passaro et al., 2001; Inamoto et al., 2003) and in patients with primary hypertension (Ravera et al., 2001) , end-stage renal disease (Lim et al., 2001) or Parkinson disease under long-term treatment with L-DOPA (Nakaso et al., 2003) . However, some reports failed to show an association between the MTHFR gene C677T polymorphism and the severity of carotid atherosclerosis (Spence et al., 1996; Zuliani et al., 2000; Zuntar et al., 2003; Manolio et al., 2004) . Thus, no consensus on the relationship between MTHFR and C677T polymorphism and carotid atherosclerosis has been reached.
Other than MTHFR genotype, age and plasma folate, vitamin B 12 and vitamin B 6 concentrations are independent determinants of plasma Hcy in middle-aged and elderly Chinese men and women (Saw et al., 2001) . Therefore, the B-group vitamins (folate, vitamin B 6 and vitamin B 12 ) and age may both be modification factors in the pathogenesis of MTHFR-related carotid atherosclerosis. Accordingly, age and plasma concentrations of B-group vitamins should be considered in the study of MTHFR-related carotid atherosclerosis. Here, we report a study on the relationship between the MTHFR 677TT genotype and carotid atherosclerosis in a healthy Taiwanese population with control for B-group vitamins concentrations and age.
Materials and methods

Subjects
Healthy subjects aged 30-80 years were recruited from health-promotion clinic, Changhua Christian Hospital in Changhua, Taiwan. All the subjects were in good health, as determined by a medical history, physical examination and routine screening laboratory analyses and were free from any cardio-vascular diseases by internist and family doctors. A total of 541 subjects without hyperlipidemia (normal levels of total cholesterol, low-density lipoprotein cholesterol and triglyceride), alcoholism, diabetes (fasting blood sugar o110 mg/dl) and hypertension (systolic BP o135 mmHg and diastolic BP o85 mmHg) were recruited from July 2002 to June 2005. Subjects on active medication were excluded. Participants were requested to complete the previously validated Youth/Adolescent Food Frequency Questionnaire (Rockett et al., 1997) , which is a self-administered, semiquantitative food frequency questionnaire that contains 131 foods with response categories for the frequency of consumption in terms of food items. The baseline characteristics of the subjects, including their smoking history and usual consumption of fruits, vegetables and meat are shown in Table 1 . Smoking index was calculated by the pack number of cigarettes smoked per day multiplying years of smoking. None of the subjects consumed alcohol or used vitamin supplements regularly, which means taking alcohol or vitamin supplements regularly more than 2 days in a week.
Informed consent for study enrollment was obtained from each of the subjects, and all of the human experimental procedures were in accordance with the ethical standards of Changhua Christian Hospital.
Biochemical measurements and MTHFR C677T polymorphism Blood samples were taken in the morning after the subjects had fasted overnight and before they had smoked any cigarettes. A total of 5 ml of blood was withdrawn from an antecubital vein into heparin-containing plastic tubes. Plasma was collected by centrifugation within 30 min of venipuncture to avoid cell production of Hcy, which can lead to falsely high plasma Hcy concentrations (Boushey et al., 1995) . Aliquots of plasma were stored at À801C for the measurement of total Hcy, folate, vitamin B 6 and vitamin B 12 . Tests were performed within 2 weeks of sample collection. The total Hcy concentration of plasma was measured by the high-performance liquid chromatography method described by Dudman et al. (1996) . Plasma vitamin B 6 concentrations were measured with a B 6 reagent kit (Chromsystems Instruments & Chemicals GmbH, Munich, Germany). Plasma levels of folate and vitamin B 12 were analyzed by radioimmunoassay (ICN Pharmaceuticals, Inc., Costa Mesa, CA, USA) according to the manufacturer's instructions. DNA was extracted from frozen peripheral blood lymphocytes by using a genomic DNA purification kit (Gentra Systems, Minneapolis, MN, USA). The MTHFR C677T polymorphism was analysed by using polymerase chain reaction followed by restriction enzyme analysis with Hinf I (Schmitz et al., 1996) .
Measurement of mean IMT in carotid arteries
IMT of bilateral common carotid arteries were measured by using a carotid ultrasound system according to the method of Salonen and Salonen (1993) with minor modifications. A 7.5-10 MHz linear array transducer (Agilent Sonos 5500; Philips, Bothell, USA) was used. The subject reclined on the examination bed for 10 min before the initial carotid ultrasound scanning. The far wall of either common carotid artery was measured. Longitudinal scanning was performed from the common carotid artery to the bifurcation. After the bifurcation of the common carotid artery was confirmed, IMT measurements were taken at four points from the B-mode screen 1 and 2 cm proximal to either bifurcation. Four individual IMT measurements were made in one scan that was synchronized with the electrocardiogram. Actual IMT value was calculated according to the average of the IMT values from four measurements. The validity and reproducibility of the IMT measurement were confirmed by using 10 volunteers. Two observers were involved in each IMT measurement. The intraobserver coefficients of variation for the IMT measurements were 3.3170.61% and 2.8570.57%, respectively. There was no significant difference between the interobserver variations in IMT scoring (95% confidence interval : À0.032, 0.016; P ¼ 0.496).
Statistical analysis
Analysis of variance (ANOVA), the general linear models procedure and w2 tests were used to analyze differences in age, sex, body mass index (BMI), smoking index, diet behavior, plasma vitamin B 6 , vitamin B 12 , folate and Hcy by MTHFR genotype. Linear regression analysis was used to examine the contribution of plasma Hcy to carotid IMT. Multicovariate ANOVA was also applied to examine MTHFRrelated hyperhomocysteinemia and the MTHFR-related increase in carotid IMT with stratification by age (age 450 and age o50) and plasma concentrations of the B-group vitamins (higher and lower; dichotomized by the mean concentrations of vitamin B 6 , vitamin B 12 and folate in Table 1 ) with control for sex, cigarette smoking and BMI. All statistical analyses were performed by using the SPSS Statistical Package for the Social Sciences (version 10.05; SPSS UK Ltd., Surrey, UK). Significance was assigned at Po0.05.
Results
Subjects and MTHFR genotype
None of the subjects in the recruited population had a deficiency of B-group vitamins or extremely high plasma Hcy concentrations. The distribution of MTHFR genotypes is consistent with published data from Taiwan (Lin et al., 2000) and is in agreement with the expected Hardy-Weinberg ratio. No significant differences in age, sex, BMI, diet behavior or smoking index according to MTHFR genotype were observed (Table 1) .
Hcy, B-group vitamins and MTHFR genotype Plasma folate concentrations were significantly lower and plasma Hcy concentrations were significantly higher in the subjects with the TT genotype than in those with the CC or CT genotype (Table 1 ). IMT was not significantly different in subjects with the TT genotype than in those with the CC or CT genotype (Table 1) .
Contribution of demographic variables, smoking, B-group vitamins concentrations and MTHFR genotype to plasma Hcy and carotid IMT In the linear regression model with fasting Hcy as the dependent variable, age was significantly positively associated with plasma Hcy. In contrast, vitamin B 12 , vitamin B 6 , folate and MTHFR genotype were negatively correlated with plasma Hcy (Table 2) . Age, sex, BMI and plasma Hcy were independently correlated with carotid IMT. However, MTHFR genotype was significantly related to carotid IMT only in the model that excluded plasma Hcy (Table 3) . Even, we recruited the factors into the regression model, including each serving of diet. The correlations were still found with the similar results as shown in Tables 2 and 3 . MTHFR-related alteration of plasma Hcy and increase in carotid IMT with stratification for age and B-group vitamins concentrations As shown in Figures 1 and 2 , IMT of the common carotid arteries was significantly higher in subjects with the TT genotype than in those with the CT or CC genotype in the subjects with folate concentrations o8.3 ng/ml and aged 450 years and in the subjects with vitamin B 12 concentrations o618 pg/ml and aged 450 years. As shown in Figures 3 and 4, plasma Hcy was significantly higher in subjects with the TT genotype than in those with the CT or CC genotype of MTHFR, in the subjects with folate concentrations o8.3 ng/ml and aged 450 years and in the subjects with vitamin B 12 concentrations o618 pg/ml and aged 450 years. Stratification of the subjects according to vitamin B 6 concentrations (above or below 36 ng/ml) did not result in significant differences in plasma Hcy or carotid IMT according to genotype and age (data not shown).
Discussion
In patients with type II diabetes, lower plasma folate concentrations may enhance the tendency for increased plasma Hcy concentrations in subjects with the MTHFR 677TT genotype (Scaglione et al., 2002) . Uremic patients with lower concentrations of folate and who were carriers of the MTHFR T allele also had a high incidence of carotid plaque formation and atherosclerotic vascular disease (Haraki et al., 2001) . In another study, subjects with the MTHFR 677TT genotype and lower folate intake or lower plasma folate concentrations had significantly higher plasma Hcy concentrations. However, this was not the case in the subjects with higher folate intake or higher plasma folate concentrations (McQuillan et al., 1999) . Selhub et al. (1995) found that plasma concentrations of folate and vitamin B 6 are inversely associated with carotid artery stenosis after adjustment for age, sex and other risk factors. MTHFR 677TT genotype is more closely related to the rise of Hcy in patients with a lower folate concentration, which highlights the effects of nutrition on MTHFR 677TT-related atherosclerosis (Christensen et al., 1997; Girelli et al., 2003) . These studies all indicate that alterations in plasma B-group vitamins, especially in plasma folate, may be related to the pathogenesis of MTHFR-related carotid atherosclerosis.
In the present study, we found that subjects with the 677TT genotype had higher concentrations of plasma Hcy combined with lower concentrations of plasma folate, but those having this genotype failed to correlate carotid atherosclerosis as assessed by IMT. However, the 677TT Bree et al. (2003) reported that giving MTHFR 677CC and CT subjects 250 mg of folate/day resulted in no significant difference in the subjects plasma Hcy concentrations. However, at the same folate dosage, 677TT subjects still had a significantly higher plasma Hcy concentration than did the 677CC/CT subjects (de Bree et al., 2003) . In our previous study, patients with cerebrovascular disease were treated with a 5 mg/day folate supplement for 8 weeks. We found that the plasma Hcy-lowering effect of the folate supplement was significant in subjects with the 677T allele but not in 677C carriers (Liu et al., 2004) . These findings may provide a rational explanation for the inconsistent conclusion of studies of MTHFR C677T-related carotid atherosclerosis (Hamelahti et al., 2002; Scaglione et al., 2002) .
In summary, we found that age and concentrations of folate, vitamin B 6 and vitamin B 12 are contributing factors to the alteration in plasma Hcy. MTHFR 677TT carriers had lower concentrations of plasma folate and higher concentrations of plasma Hcy than did subjects harboring the CC and CT genotypes. Age, sex, BMI and plasma Hcy, but not the MTHFR 677TT genotype, were independent factors contributing to the increased IMT of common carotid arteries. However, with stratification for age and B-group vitamins concentrations, we found that older age, lower plasma folate concentrations and lower vitamin B 12 concentrations can enhance the effect of the MTHFR 677TT allele and increase of plasma Hcy and indirectly modify the progress of carotid IMT. These findings may explain, at least partly, inconsistent conclusions of previous studies of the contribution of the MTHFR C677 polymorphism to carotid atherosclerosis. Nutritional status and age must be two critical factors involved in the prediction of causal relationship between MTHFR genotype and atherosclerosis.
